Pure Biologics Spólka Akcyjna (PUR.WA)

PLN 15.22

(-8.86%)

Total Debt Summary of Pure Biologics Spólka Akcyjna

Pure Biologics Spólka Akcyjna's latest annual total debt in 2023 was 12.93 Million PLN , up 352.22% from previous year.
Pure Biologics Spólka Akcyjna's latest quarterly total debt in 2024 Q2 was 13.31 Million PLN , up 1.76% from previous quarter.
Pure Biologics Spólka Akcyjna reported annual total debt of 2.86 Million PLN in 2022, down -8.1% from previous year.
Pure Biologics Spólka Akcyjna reported annual total debt of 3.11 Million PLN in 2021, down -37.8% from previous year.
Pure Biologics Spólka Akcyjna reported quarterly total debt of 13.25 Million PLN for 2024 Q1, up 2.46% from previous quarter.
Pure Biologics Spólka Akcyjna reported quarterly total debt of 12.93 Million PLN for 2023 Q4, down -68.72% from previous quarter.

Annual Total Debt Chart of Pure Biologics Spólka Akcyjna (2023 - 2016)

Historical Annual Total Debt of Pure Biologics Spólka Akcyjna (2023 - 2016)

Year	Total Debt	Total Debt Growth
2023	12.93 Million PLN	352.22%
2022	2.86 Million PLN	-8.1%
2021	3.11 Million PLN	-37.8%
2020	5 Million PLN	-6.85%
2019	5.37 Million PLN	5626.01%
2018	93.83 Thousand PLN	-39.46%
2017	154.99 Thousand PLN	0.0%
2016	- PLN	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	13.31 Million PLN	1.76%
2024 Q1	13.25 Million PLN	2.46%
2023 Q4	12.93 Million PLN	-68.72%
2023 Q1	30.72 Million PLN	973.89%
2023 FY	12.93 Million PLN	352.22%
2023 Q2	42.12 Million PLN	37.11%
2023 Q3	41.35 Million PLN	-1.82%
2022 Q4	2.86 Million PLN	23.96%
2022 Q3	2.3 Million PLN	-12.84%
2022 FY	2.86 Million PLN	-8.1%
2022 Q2	2.64 Million PLN	-17.43%
2022 Q1	3.2 Million PLN	3.02%
2021 Q2	4.17 Million PLN	-3.94%
2021 FY	3.11 Million PLN	-37.8%
2021 Q4	3.11 Million PLN	-11.81%
2021 Q3	3.53 Million PLN	-15.37%
2021 Q1	4.34 Million PLN	-13.25%
2020 Q4	5 Million PLN	-29.67%
2020 FY	5 Million PLN	-6.85%
2020 Q3	7.11 Million PLN	2.8%
2020 Q1	2.45 Million PLN	-28.09%
2020 Q2	6.92 Million PLN	181.64%
2019 Q2	1.51 Million PLN	952.74%
2019 FY	5.37 Million PLN	5626.01%
2019 Q4	3.41 Million PLN	12.51%
2019 Q3	3.03 Million PLN	99.93%
2019 Q1	144.33 Thousand PLN	53.82%
2018 Q3	83.78 Thousand PLN	0.0%
2018 FY	93.83 Thousand PLN	-39.46%
2018 Q1	- PLN	-100.0%
2018 Q4	93.83 Thousand PLN	12.0%
2017 FY	154.99 Thousand PLN	0.0%
2017 Q4	154.99 Thousand PLN	0.0%
2016 FY	- PLN	0.0%

Peer Total Debt Comparison of Pure Biologics Spólka Akcyjna

Name	Total Debt	Total Debt Difference
Bioceltix S.A.	175.05 Thousand PLN	-7290.736%
BIOTON S.A.	68.69 Million PLN	81.165%
Captor Therapeutics Spolka Akcyjna	3.77 Million PLN	-242.456%
Mabion S.A.	35.82 Million PLN	63.889%
Molecure S.A.	7.13 Million PLN	-81.22%
NanoGroup S.A.	- PLN	-Infinity%
Pharmena S.A.	181 Thousand PLN	-7048.066%
Poltreg S.A.	8.19 Million PLN	-57.896%
Ryvu Therapeutics S.A.	906 Thousand PLN	-1328.035%
Synthaverse S.A.	70.04 Million PLN	81.528%
Urteste S.A.	627 Thousand PLN	-1963.477%